Patents Assigned to AvenCell Europe GmbH - Justia Patents Search

Patents Assigned to AvenCell Europe GmbH

Targeting modules for universal chimeric antigen receptor expressing immune cells and use in the treatment of cancer, infections and autoimmune disorders

Patent number: 12173063

Abstract: The present invention relates to a targeting module comprising a chemically synthesized peptide binding moiety specific for a human cell surface protein or protein complex, a kit comprising the targeting module and a vector or a cell comprising a nucleic acid encoding a universal chimeric antigen receptor and the use for the treatment of cancer, infections and autoimmune disorders.

Type: Grant

Filed: December 19, 2022

Date of Patent: December 24, 2024

Assignee: AvenCell Europe GmbH

Inventor: Armin Ehninger
Targeting modules for universal chimeric antigen receptor expressing immune cells and use in the treatment of cancer infections and autoimmune disorders

Patent number: 11560426

Abstract: The present invention relates to a targeting module comprising a chemically synthesized peptide binding moiety specific for a human cell surface protein or protein complex, a kit comprising the targeting module and a vector or a cell comprising a nucleic acid encoding a universal chimeric antigen receptor and the use for the treatment of cancer, infections and autoimmune disorders.

Type: Grant

Filed: June 8, 2018

Date of Patent: January 24, 2023

Assignee: AvenCell Europe GmbH

Inventor: Armin Ehninger